The small guanosine triphosphate (GTP) binding protein Ras is involved in m
any cellular signal transduction processes leading to cell growth, differen
tiation and apoptosis. Mutations in ras genes are found in a large number o
f human tumours. GTP hydrolysis, the process that normally leads to the tra
nsition of the Ras protein from the active (GTP-bound) form to the inactive
(GDP-bound) form is impaired due to these oncogenic mutations. In contrast
, the GTP analogue 3,4-diaminobenzophenone(DASP)-phosphoramidate-GTP, a sub
strate for GTP-binding proteins, enables switching to the inactive GDP form
in both wild-type and oncogenic Ras. Here we show by HPLC, mass spectromet
ry and NMR spectroscopy that the mechanism of this DABP-GTPase reaction is
different from the physiological GTPase reaction. The gamma -phosphate grou
p is not attacked by a nucleophilic water molecule, but rather by,the aroma
tic amino group of the analogue, which leads to the generation of a stable
cyclic diamidate product, These findings, hove potential implications for t
he development of anti-Ras drugs.